Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,896 public trials 1,789 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer

NCT00849329

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Greenville, South Carolina, United States
  • GSK Investigational Site Seoul, South Korea
  • GSK Investigational Site Songpa-gu, Seoul, South Korea
  • GSK Investigational Site Hospitalet de Llobregat (Barcelona), Spain
View Trial Details
Completed

A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients

NCT00821054

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Buffalo, New York, United States
  • GSK Investigational Site Greenville, South Carolina, United States
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View Trial Details
Completed

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

NCT00359190

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Durham, North Carolina, United States
  • GSK Investigational Site Allentown, Pennsylvania, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib

NCT00996762

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Fort Myers, Florida, United States
View Trial Details

Related conditions